These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35292188)

  • 21. Predictors of sentinel lymph node status of cutaneous melanoma in Serbian patients.
    Jokic S; Markovic I; Bukumiric Z; Jokic V; Rakovic M; Tripkovic J; Stojiljkovic D; Spurnic I; Jevric M; Matic M; Dobrosavljevic D
    J BUON; 2018; 23(2):468-474. PubMed ID: 29745094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients.
    Cuéllar FA; Vilalta A; Rull R; Vidal-Sicart S; Palou J; Ventura PJ; Pous E; Quinto L; Malvehy J; Martí R; Puig S; Vilella R; Soler J; Benítez D; Yachi E; Lecha M; Pons F; Conill C; Visa J; Castel T;
    Melanoma Res; 2004 Aug; 14(4):277-82. PubMed ID: 15305158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
    Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
    Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of sentinel lymph node status in cutaneous melanoma: a classification and regression tree analysis.
    Tejera-Vaquerizo A; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Traves V; Herrera-Ceballos E; Nagore E
    Actas Dermosifiliogr; 2015 Apr; 106(3):208-18. PubMed ID: 25616352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
    Oh Y; Choi S; Cho MY; Nam KA; Shin SJ; Chang JS; Oh BH; Roh MR; Chung KY
    J Am Acad Dermatol; 2020 Oct; 83(4):1071-1079. PubMed ID: 31562946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of clinical and histopathological characteristics on the disease-free survival of stage I-II acral melanoma patients.
    Borges de Barros Primo R; Brito Nobre A; Santos BN; Nunes LF; Fernandes R; Abrão Possik P; Santos Bernardes S
    Int J Dermatol; 2023 Oct; 62(10):1281-1288. PubMed ID: 37596798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
    Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
    Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
    Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
    Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
    Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
    Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
    Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.
    Lachiewicz AM; Berwick M; Wiggins CL; Thomas NE
    Arch Dermatol; 2008 Apr; 144(4):515-21. PubMed ID: 18427046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results.
    Vuylsteke RJ; van Leeuwen PA; Statius Muller MG; Gietema HA; Kragt DR; Meijer S
    J Clin Oncol; 2003 Mar; 21(6):1057-65. PubMed ID: 12637471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic invasion in acral and non-acral melanoma: a comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site.
    Jung JM; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
    Pathology; 2020 Oct; 52(6):670-675. PubMed ID: 32819739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up.
    Leong SP; Kashani-Sabet M; Desmond RA; Kim RP; Nguyen DH; Iwanaga K; Treseler PA; Allen RE; Morita ET; Zhang Y; Sagebiel RW; Soong SJ
    World J Surg; 2005 Jun; 29(6):683-91. PubMed ID: 15895193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
    Vízkeleti L; Ecsedi S; Rákosy Z; Orosz A; Lázár V; Emri G; Koroknai V; Kiss T; Ádány R; Balázs M
    Tumour Biol; 2012 Dec; 33(6):2189-99. PubMed ID: 23001925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
    Wei X; Wu D; Li H; Zhang R; Chen Y; Yao H; Chi Z; Sheng X; Cui C; Bai X; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Mao L; Lian B; Kong Y; Dai J; Tang B; Yan X; Wang X; Li S; Zhou L; Balch CM; Si L; Guo J
    Ann Surg Oncol; 2020 Sep; 27(9):3478-3485. PubMed ID: 32253677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphatic vessel density and VEGF-C expression as independent predictors of melanoma metastases.
    Špirić Z; Eri Ž; Erić M
    J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1653-1659. PubMed ID: 28756123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.